Ovarian cancer cells treated in vitro with CCL2/MCP-1 and carboplatin significantly increased spheroid formation ability and increased SOX2 expression, suggesting that CCL2/MCP-1 could be one of the secreted factors from macrophages during chemotherapy that supports CSC features. Here, SOX2 is linked to ovarian carcinoma.